Altimmune(DE:3G0)
€1.550.00 (-10.42%)
DE:3G0
Altimmune earnings date
€1.55
At close:0.00 (-10.42%)
Altimmune (3G0) Q2 2021 Earnings Report
9 Followers
DE:3G0 Q2 2021 EPS Results
- Actual EPS
- -EUR 0.54
- Consensus EPS
- -EUR 0.46
- Beat/Miss
- Missed by -EUR 0.09
- One Year Ago EPS
- -EUR 0.85
DE:3G0 Q2 2021 Revenue Results
- Actual Revenue
- EUR 124.84K
- Expected Revenue
- EUR 1.72M
- Beat/Miss
- Missed by -EUR 1.59M
- YoY Revenue Growth
- -80.93%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/10/2021
- Time
- After Close
- Conference Call
- Tuesday, August 10, 2021
DE:3G0 Upcoming Earnings
Altimmune's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3G0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.15- | -0.24 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.12-0.14 | -0.19 | 28.57% (+0.05) | |
| Aug 12, 2026 | 2026 (Q2) | -0.13-0.11 | -0.24 | 55.56% (+0.14) | |
| May 13, 2026 | 2026 (Q1) | -0.22-0.16 | -0.24 | 30.77% (+0.07) | |
| Mar 05, 2026 | 2025 (Q4) | -0.22-0.24 | -0.3 | 18.18% (+0.05) | |
| Nov 06, 2025 | 2025 (Q3) | -0.25-0.19 | -0.29 | 34.38% (+0.10) | |
| Aug 12, 2025 | 2025 (Q2) | -0.30-0.24 | -0.32 | 22.86% (+0.07) | |
| May 13, 2025 | 2025 (Q1) | -0.32-0.24 | -0.31 | 23.53% (+0.07) | |
| Feb 27, 2025 | 2024 (Q4) | -0.30-0.30 | -0.49 | 38.89% (+0.19) | |
| Nov 12, 2024 | 2024 (Q3) | -0.32-0.29 | -0.35 | 17.95% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
